Please assess the completion status of the following clinical trial:

Trial Title: FACBC Positron Emission Tomography/Computed Tomography(PET/CT) Used in the Diagnosis of Primary Prostate Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients must be 18 years of age or older.~* Patients will be scheduled for prostatectomy based on a diagnosis of primary prostate cancer.~* Ability to lie still for PET scanning~* Patients must be able to provide written informed consent.~Exclusion Criteria:~* Age less than 18~* Inability to lie still for PET scanning~* Cannot provide written informed consent.~* Less than 4 weeks since any prior prostate biopsy (to decrease false positive uptake from inflammation).

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- FACBC Imaging (Type: EXPERIMENTAL): Dynamic FACBC PET of primary prostate carcinoma.

Based on this trial design, predict the completion outcome and termination type (if applicable).